全文获取类型
收费全文 | 178675篇 |
免费 | 33808篇 |
国内免费 | 4697篇 |
专业分类
耳鼻咽喉 | 5466篇 |
儿科学 | 5678篇 |
妇产科学 | 2713篇 |
基础医学 | 6459篇 |
口腔科学 | 2004篇 |
临床医学 | 30478篇 |
内科学 | 51170篇 |
皮肤病学 | 7764篇 |
神经病学 | 16147篇 |
特种医学 | 7376篇 |
外国民族医学 | 16篇 |
外科学 | 43332篇 |
综合类 | 5267篇 |
现状与发展 | 78篇 |
一般理论 | 6篇 |
预防医学 | 9104篇 |
眼科学 | 4177篇 |
药学 | 4151篇 |
19篇 | |
中国医学 | 1777篇 |
肿瘤学 | 13998篇 |
出版年
2024年 | 777篇 |
2023年 | 5208篇 |
2022年 | 2367篇 |
2021年 | 4565篇 |
2020年 | 7165篇 |
2019年 | 3162篇 |
2018年 | 8381篇 |
2017年 | 8359篇 |
2016年 | 9329篇 |
2015年 | 9695篇 |
2014年 | 17160篇 |
2013年 | 17132篇 |
2012年 | 7656篇 |
2011年 | 7814篇 |
2010年 | 11790篇 |
2009年 | 15366篇 |
2008年 | 7285篇 |
2007年 | 5506篇 |
2006年 | 7828篇 |
2005年 | 5110篇 |
2004年 | 3932篇 |
2003年 | 2869篇 |
2002年 | 2817篇 |
2001年 | 4441篇 |
2000年 | 3582篇 |
1999年 | 3793篇 |
1998年 | 4037篇 |
1997年 | 3816篇 |
1996年 | 3624篇 |
1995年 | 3485篇 |
1994年 | 2187篇 |
1993年 | 1733篇 |
1992年 | 1569篇 |
1991年 | 1590篇 |
1990年 | 1187篇 |
1989年 | 1312篇 |
1988年 | 1142篇 |
1987年 | 947篇 |
1986年 | 960篇 |
1985年 | 771篇 |
1984年 | 571篇 |
1983年 | 559篇 |
1982年 | 517篇 |
1981年 | 415篇 |
1980年 | 371篇 |
1979年 | 321篇 |
1978年 | 335篇 |
1977年 | 404篇 |
1975年 | 281篇 |
1972年 | 306篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
Srdan Verstovsek MD PhD Jean-Jacques Kiladjian MD PhD Alessandro M. Vannucchi MD Ruben A. Mesa MD FACP Peg Squier MD PhD J. E. Hamer-Maansson MSPH Claire Harrison MD 《Cancer》2023,129(11):1681-1690
Background
In a pooled analysis of the phase 3 Controlled Myelofibrosis Study With Oral JAK Inhibitor Treatment I (COMFORT-I) and COMFORT-II clinical trials, adult patients with intermediate-2 or high-risk myelofibrosis who received oral ruxolitinib at randomization or after crossover from placebo or best available therapy (BAT) had improved overall survival (OS).Methods
This post hoc analysis of pooled COMFORT data examined relevant disease outcomes based on the disease duration (≤12 or >12 months from diagnosis) before ruxolitinib initiation.Results
The analysis included 525 patients (ruxolitinib: ≤12 months, n = 84; >12 months, n = 216; placebo/BAT: ≤12 months, n = 66; >12 months, n = 159); the median age was 65.0–70.0 years. Fewer thrombocytopenia and anemia events were observed among patients who initiated ruxolitinib treatment earlier. At Weeks 24 and 48, the spleen volume response (SVR) was higher for patients who initiated ruxolitinib earlier (47.6% vs. 32.9% at Week 24, p = .0610; 44.0% vs. 26.9% at Week 48, p = .0149). In a multivariable analysis of factors associated with spleen volume reduction, a logistic regression model that controlled for confounding factors found that a significantly greater binary reduction was observed among patients with shorter versus longer disease duration (p = .022). At Week 240, OS was significantly improved among patients who initiated ruxolitinib earlier (63% [95% CI, 51%‒73%] vs. 57% [95% CI, 49%‒64%]; hazard ratio, 1.53; 95% CI, 1.01‒2.31; p = .0430). Regardless of disease duration, a longer OS was observed for patients who received ruxolitinib versus those who received placebo/BAT.Conclusions
These findings suggest that earlier ruxolitinib initiation for adult patients with intermediate-2 and high-risk myelofibrosis may improve clinical outcomes, including fewer cytopenia events, durable SVR, and prolonged OS.Plain Language Summary
- Patients with myelofibrosis, a bone marrow cancer, often do not live as long as the general population. These patients may also have an enlarged spleen and difficult symptoms such as fatigue.
- Two large clinical trials showed that patients treated with the drug ruxolitinib lived longer and had improved symptoms compared to those treated with placebo or other standard treatments.
- Here it was examined whether starting treatment with ruxolitinib earlier (i.e., within a year of diagnosis) provided benefits versus delaying treatment.
- Patients who received ruxolitinib within a year of diagnosis lived longer and experienced fewer disease symptoms than those whose treatment was delayed.
4.
Kui Li Jiawen Wang Shengxiong Liu Sen Su Chenjian Feng Xiaoxiang Fan Zhiyong Yin 《中华创伤杂志(英文版)》2015,18(2):65-73
Objective: To study the biomechanical mechanism of head injuries beaten with sticks, which is common in the battery or assaultive cases.
Methods: In this study, the Hybrid-III anthropomorphic test device and finite element model (FEM) of the total human model for safety (THUMS) head were used to determine the biomechanical response of head while being beaten with different sticks. Total eight Hybrid-III tests and four finite element simulations were conducted. The contact force, resultant acceleration of head center of gravity, intracranial pressure and von Mises stress were calculated to determine the different biomechanical behavior of head with beaten by different sticks.
Results: In Hybrid-III tests, the stick in each group demonstrated the similar kinematic behavior under the same loading condition. The peak values of the resultant acceleration for thick iron stick group, thin iron stick group, thick wooden stick group and thin wooden stick group were 203.4 g, 221.1 g, 170.5 g and 122.2 g respectively. In finite element simulations, positive intracranial pressure was initially observed in the frontal comparing with negative intracranial pressure in the contra-coup site. Subsequently the intracranial pressure in the coup site was decreasing toward negative value while the contra-coup intracranial pressure increasing toward positive values.
Conclusions: The results illustrated that the stiffer and larger the stick was, the higher the von Mises stress, contact force and intracranial pressure were. We believed that the results in the Hybrid-III tests and THUMS head simulations for brain injury beaten with sticks could be reliable and useful for better understanding the injury mechanism. 相似文献
5.
Elizabeth A. Mosley PhD MPH Amy J. Schulz PhD MPH MSW Lisa H. Harris MD PhD Barbara A. Anderson PhD 《Women & health》2020,60(7):806-820
ABSTRACT Abortion is legal in South Africa, but negative abortion attitudes remain common and are poorly understood. We used nationally representative South African Social Attitudes Survey data to analyze abortion attitudes in the case of fetal anomaly and in the case of poverty from 2007 to 2016 (n = 20,711; ages = 16+). We measured correlations between abortion attitudes and these important predictors: religiosity, attitudes about premarital sex, attitudes about preferential hiring and promotion of women, and attitudes toward family gender roles. Abortion acceptability for poverty increased over time (b = 0.05, p < .001), but not for fetal anomaly (b = ?0.008, p = .284). Highly religious South Africans reported lower abortion acceptability in both cases (Odds Ratio (OR)anomaly = 0.85, p = .015; ORpoverty = 0.84, p = .02). Premarital sex acceptability strongly and positively predicted abortion acceptability (ORanomaly = 2.63, p < .001; ORpoverty = 2.46, p < .001). Attitudes about preferential hiring and promotion of women were not associated with abortion attitudes, but favorable attitudes about working mothers were positively associated with abortion acceptability for fetal anomaly ((ORanomaly = 1.09, p = .01; ORpoverty = 1.02, p = .641)). Results suggest negative abortion attitudes remain common in South Africa and are closely tied to religiosity, traditional ideologies about sexuality, and gender role expectations about motherhood. 相似文献
6.
7.
目的:通过对羽毛球爱好者的问卷调查,结合羽毛球项目的运动特点,分析常见的运动损伤部位及其发病原因、处理方法以及预防措施.
方法:调查于2005—03/11在成都医学院体育教研室羽毛球俱乐部完成,对156名羽毛球爱好者进行运动损伤情况凋查,均自愿参加调查。采用问卷调查和专家访谈相结合的方法,主要结合羽毛球项目的运动特点,调查运动损伤的患病率、损伤类型及其受伤原因,分析其常用的处理方法及预防措施。
结果:共发放问卷156份,收回内容详实问卷156份。(1)损伤患病率:运动损伤患病率为78,84%。(2)损伤类型:156名羽毛球爱好者中急性损伤占52、56%,慢性损伤占26,28%。最容易受伤的手腕处受伤患病率为37.39%,其次是肩袖受伤患病率为30.89%。(3)受伤原因:技术动作不规范是运动损伤最主要的原因,占72,35%,而准备活动不充分和身体疲劳分别占63、41%和22.76%.
结论:为有效预防手腕和肩袖损伤,应加强局部肌肉力量训练等防治措施;注意学习和掌握正确的动作技术要领,做好充分的准备活动是十分必要的. 相似文献
8.
9.
10.